{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:00:19Z","timestamp":1778281219648,"version":"3.51.4"},"reference-count":50,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014191","name":"Brain Research New Zealand","doi-asserted-by":"publisher","award":["3715300"],"award-info":[{"award-number":["3715300"]}],"id":[{"id":"10.13039\/501100014191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Age-related hearing loss (ARHL) is the most common sensory disorder among older people, and yet, the treatment options are limited to medical devices such as hearing aids and cochlear implants. The high prevalence of ARHL mandates the development of treatment strategies that can prevent or rescue age-related cochlear degeneration. In this study, we investigated a novel pharmacological strategy based on inhibition of the adenosine A2A receptor (A2AR) in middle aged C57BL\/6 mice prone to early onset ARHL. C57BL\/6J mice were treated with weekly istradefylline (A2AR antagonist; 1 mg\/kg) injections from 6 to 12 months of age. Auditory function was assessed using auditory brainstem responses (ABR) to tone pips (4\u201332 kHz). ABR thresholds and suprathreshold responses (wave I amplitudes and latencies) were evaluated at 6, 9, and 12 months of age. Functional outcomes were correlated with quantitative histological assessments of sensory hair cells. Cognitive function was assessed using the Morris water maze and the novel object recognition test, and the zero maze test was used to assess anxiety-like behaviour. Weekly injections of istradefylline attenuated ABR threshold shifts by approximately 20 dB at mid to high frequencies (16\u201332 kHz) but did not improve ABR suprathreshold responses. Istradefylline treatment improved hair cell survival in a turn-dependent manner, whilst the cognitive function was unaffected by istradefylline treatment. This study presents the first evidence for the rescue potential of istradefylline in ARHL and highlights the role of A2AR in development of age-related cochlear degeneration.<\/jats:p>","DOI":"10.3390\/ijms22158000","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T12:18:31Z","timestamp":1627388311000},"page":"8000","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Istradefylline Mitigates Age-Related Hearing Loss in C57BL\/6J Mice"],"prefix":"10.3390","volume":"22","author":[{"given":"Min","family":"Shin","sequence":"first","affiliation":[{"name":"Department of Physiology and The Eisdell Moore Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland 1142, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhavi","family":"Pandya","sequence":"additional","affiliation":[{"name":"Department of Physiology and The Eisdell Moore Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland 1142, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristan","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Department of Physiology and The Eisdell Moore Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland 1142, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra","family":"Telang","sequence":"additional","affiliation":[{"name":"Department of Physiology and The Eisdell Moore Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland 1142, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8460-2567","authenticated-orcid":false,"given":"Jordi","family":"Boix","sequence":"additional","affiliation":[{"name":"Centre for Brain Research, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland 1023, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Thorne","sequence":"additional","affiliation":[{"name":"Department of Physiology and The Eisdell Moore Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland 1142, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8548-6844","authenticated-orcid":false,"given":"Srdjan M.","family":"Vlajkovic","sequence":"additional","affiliation":[{"name":"Department of Physiology and The Eisdell Moore Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland 1142, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2021, March 03). World Report on Hearing. Available online: https:\/\/www.who.int\/publications\/i\/item\/world-report-on-hearing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1093\/geront\/gnw033","article-title":"Aging and hearing health: The life-course approach","volume":"56","author":"Davis","year":"2016","journal-title":"Gerontologist"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.heares.2013.01.021","article-title":"Current concepts in age related hearing loss: Epidemiology and mechanistic pathways","volume":"303","author":"Yamasoba","year":"2013","journal-title":"Hear. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnins.2018.00125","article-title":"Impact of aging on the auditory system and related cognitive functions: A narrative review","volume":"12","author":"Jayakody","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/00034894931020S101","article-title":"Cochlear pathology in presbyacusis","volume":"102","author":"Schuknecht","year":"1993","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(05)67423-5","article-title":"Presbycusis","volume":"366","author":"Gates","year":"2005","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.heares.2006.06.004","article-title":"Role of mitochondrial dysfunction and mitochondrial DNA mutations in age-related hearing loss","volume":"226","author":"Yamasoba","year":"2007","journal-title":"Hear. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1152\/physrev.00053.2017","article-title":"Toward cochlear therapies","volume":"98","author":"Wang","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.arr.2017.10.002","article-title":"Chronic inflammation\u2014inflammaging\u2014in the ageing cochlea: A novel target for future presbycusis therapy","volume":"40","author":"Watson","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0378-5955(99)00003-9","article-title":"Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses","volume":"130","author":"Zheng","year":"1999","journal-title":"Hear. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2006.03.017","article-title":"Contributions of mouse models to understanding of age- and noise-related hearing loss","volume":"1091","author":"Ohlemiller","year":"2006","journal-title":"Brain Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0378-5955(03)00211-9","article-title":"The functional age of hearing loss in a mouse model of presbyacusis. I. Behavioral assessments","volume":"183","author":"Prosen","year":"2003","journal-title":"Hear. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13041-016-0191-9","article-title":"Age-related changes in behaviour in C57BL\/6J mice from young adulthood to middle age","volume":"9","author":"Shoji","year":"2016","journal-title":"Mol. Brain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.heares.2009.12.004","article-title":"Post exposure administration of A1 adenosine receptor agonists attenuates noise-induced hearing loss","volume":"260","author":"Wong","year":"2010","journal-title":"Hear. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11302-010-9188-5","article-title":"Adenosine amine congener mitigates noise-induced cochlear injury","volume":"6","author":"Vlajkovic","year":"2010","journal-title":"Purinergic Signal."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5319\/wjo.v3.i3.100","article-title":"Adenosine Amine Congener ameliorates cisplatin-induced hearing loss","volume":"3","author":"Gunewardene","year":"2013","journal-title":"World J. Otorhinolaryngol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fncel.2019.00207","article-title":"Purinergic signalling and aminoglycoside ototoxicity: The opposing roles of P1 (adenosine) and P2 (ATP) receptors on cochlear hair cell survival","volume":"13","author":"Lin","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/157015909789152155","article-title":"Adenosine and the auditory system","volume":"7","author":"Vlajkovic","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"ref_20","first-page":"265","article-title":"Adenosine receptors as drug targets\u2014What are the challenges?","volume":"12","author":"Chen","year":"2013","journal-title":"Nat. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-12-801022-8.00012-X","article-title":"Adenosine receptor control of cognition in normal and disease","volume":"119","author":"Chen","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2015.10.031","article-title":"Purinergic receptors as potential therapeutic targets in Alzheimer\u2019s disease","volume":"104","author":"Woods","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.heares.2016.12.015","article-title":"Adenosine receptors regulate susceptibility to noise-induced neural injury in the mouse cochlea and hearing loss","volume":"345","author":"Vlajkovic","year":"2017","journal-title":"Hear. Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Han, B.R.X., Lin, S.C.Y., Espinosa, K., Thorne, P.R., and Vlajkovic, S.M. (2019). Inhibition of the adenosine A2A receptor mitigates excitotoxic injury in organotypic tissue cultures of the rat cochlea. Cells, 8.","DOI":"10.3390\/cells8080877"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"18018","DOI":"10.1038\/s41598-017-18339-1","article-title":"The effect of istradefylline for Parkinson\u2019s disease: A meta-analysis","volume":"7","author":"Sako","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1517\/13543784.14.6.729","article-title":"Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson\u2019s disease","volume":"14","author":"Jenner","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40263-014-0161-7","article-title":"Adenosine A2A receptor antagonists in Parkinson\u2019s disease: Progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued","volume":"28","author":"Pinna","year":"2014","journal-title":"CNS Drugs"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/14728214.2011.552427","article-title":"Emerging treatments for noise-induced hearing loss","volume":"16","author":"Oishi","year":"2011","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5955(01)00224-6","article-title":"Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals","volume":"155","author":"Sha","year":"2001","journal-title":"Hear. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fncel.2015.00276","article-title":"Age-related hearing impairment and the triad of acquired hearing loss","volume":"9","author":"Yang","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1017\/S0022215100050465","article-title":"An experimental and clinical study of deafness from lesions of the cochlear nerve","volume":"69","author":"Schuknecht","year":"1955","journal-title":"J. Laryngol. Otol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.1523\/JNEUROSCI.2845-09.2009","article-title":"Adding insult to injury: Cochlear nerve degeneration after \u201ctemporary\u201d noise-induced hearing loss","volume":"29","author":"Kujawa","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.heares.2015.04.008","article-title":"No longer falling on deaf ears: Mechanisms of degeneration and regeneration of cochlear ribbon synapses","volume":"329","author":"Wan","year":"2015","journal-title":"Hear. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13686","DOI":"10.1523\/JNEUROSCI.1783-13.2013","article-title":"Age-related cochlear synaptopathy: An early-onset contributor to auditory functional decline","volume":"33","author":"Sergeyenko","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnagi.2011.00009","article-title":"Age sensitivity of behavioral tests and brain substrates of normal aging in mice","volume":"3","author":"Kennard","year":"2011","journal-title":"Front. Aging Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Development of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: Neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn. Process."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.vascn.2013.02.010","article-title":"Assessing anxiety in C57BL\/6J mice: A pharmacological characterization of the zero maze test","volume":"68","author":"Heredia","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11302-005-0649-1","article-title":"Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade","volume":"1","author":"Cunha","year":"2005","journal-title":"Purinerg. Signal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.exger.2010.11.034","article-title":"Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats","volume":"46","author":"Leite","year":"2011","journal-title":"Exp. Gerontol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","article-title":"Caffeine and adenosine A2A receptor antagonists prevent beta-amyloid (25\u201335)-induced cognitive deficits in mice","volume":"203","author":"Fett","year":"2007","journal-title":"Exp. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e1123","DOI":"10.1038\/tp.2017.98","article-title":"Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation","volume":"7","author":"Zhao","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1517\/14740338.2015.1014798","article-title":"The safety of istradefylline for the treatment of Parkinson\u2019s disease","volume":"14","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/14728222.2014.981529","article-title":"Dopamine heteroreceptor complexes as therapeutic targets in Parkinson\u2019s disease","volume":"19","author":"Fuxe","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00441-006-0374-2","article-title":"Differential distribution of adenosine receptors in rat cochlea","volume":"328","author":"Vlajkovic","year":"2007","journal-title":"Cell Tissue Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bcp.2004.01.010","article-title":"Protection against cisplatin ototoxicity by adenosine agonists","volume":"67","author":"Whitworth","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: The state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0378-5955(96)00204-3","article-title":"Expression and function of adenosine receptors in the chinchilla cochlea","volume":"105","author":"Ford","year":"1997","journal-title":"Hear. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"841489","DOI":"10.1155\/2014\/841489","article-title":"Adenosine amine congener as a cochlear rescue agent","volume":"2014","author":"Vlajkovic","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.heares.2004.04.016","article-title":"The guide to plotting a cochleogram","volume":"197","author":"Viberg","year":"2004","journal-title":"Hear. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/15\/8000\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:35:24Z","timestamp":1760164524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/15\/8000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":50,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22158000"],"URL":"https:\/\/doi.org\/10.3390\/ijms22158000","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]}}}